Section Arrow
Quote
AVXL.NASDAQ
- Anavex Life Sciences Corp
Quotes are at least 15-min delayed:2026/03/02 22:54 EST
Regular Hours
Last
 4.53
+0.095 (+2.14%)
Day High 
4.66 
Prev. Close
4.435 
1-M High
5.06 
Volume 
922.82K 
Bid
4.27
Ask
4.53
Day Low
4.301 
Open
4.31 
1-M Low
3.745 
Market Cap 
411.00M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.21 
20-SMA 4.19 
50-SMA 4.28 
52-W High 13.99 
52-W Low 2.86 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.46/-0.14
Enterprise Value
411.00M
Balance Sheet
Book Value Per Share
1.37
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio10.44+0.64+6.53%-- 
QNCXQuince Therapeutics0.0988-0.0213-17.74%-- 
OCULOcular Therapeutix10.98+2.035+22.75%-- 
QUREuniQure NV10.5-5.08-32.61%-- 
GERNGeron Corp1.55-0.13-7.74%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer'sdisease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and severalother compounds in different stages of clinical and pre-clinical development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.